Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • FemmeBreaking barriers and building confidence in investing
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • Investing SchoolGuides and lessons to grow your investing knowledge
    • Portfolio buildersInvesting knowledge for every level, from first steps to advanced portfolio strategies.
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Midsona: Volume recovery taking its time - ABG

MSON BThird party research23.10.2026 klo 08.08

This is a third party research report and does not necessarily reflect our views or values

Download report (PDF)
* Q3'26: Margin held up but volumes did not
* We cut '26e-'27e EBITA by 7-2%, mainly on North Europe
* Trading at NTM EV/EBITA of 7x

Solid margins but soft growth

Q3 missed on sales but less so on earnings (-4% on sales, -5% on adj. EBIT, i.e. SEK 3m). The gross margin was the bright spot at 29% (1.0pp above ABGSCe) on a better own-brand mix, but it could not fully offset -3.7% organic growth. The Nordics was soft on top-line (-3% org growth) and adj. EBIT fell to SEK 62m from SEK 65m on a softer price/mix and higher marketing. North Europe was the weak link, with adj. EBIT down to SEK 2m from SEK 7m on -10% organic sales after retailer de-listings and the summer heatwave. South Europe narrowed its loss to SEK -1m from SEK -6m on 10% organic growth against easy post-fire comps.

Pressure could remain in Q4

Management’s commentary on costs leads us to believe that the elevated cost base in Q3 could continue into Q4. Retailer de-listings should continue to weigh on own-brand sales, while management gives no timeline for when the measures will take effect. Cost inflation has not yet recovered through pricing, and continued marketing investments add more pressure. With the R12M adj. EBIT margin at 4.3% against the >8% 2027 target, management is deepening its brand portfolio review and intends to concentrate capital on fewer brands. We expect Midsona to prioritise margins over growth, but we believe that margin improvements in North Europe require both a mix and volumes that we have not yet seen.

We cut '26e adj. EBITA by 7%

We lower our sales and adj. EBITA estimates following the report, primarily reflecting weaker prospects for North Europe. '26e-'27e sales are down 2.2-2.5% because of the report and updated FX. Adj. EBITA is cut by 7-2% for '26e-'27e. Our EPS estimates are up due to lower than expected net financials. Based on our revised estimates, the company is trading at ~7x NTM EV/EBITA.